-
-
-
-
-
-
-
Fresenius Medical Care further accelerates organic revenue development and achieves an inflection in earnings growth, delivering 28% operating income growth in the third quarter of 2025
-
-
-
-
-
-
-
Fresenius Medical Care (FMS) Tops Q1 EPS by 7c, provides outlook
-
-
-
-
-
-
-
Fresenius Medical Care (FMS) Tops Q2 EPS by 33c
-
-
-
-
-
-
-
Fresenius Medical Care enters into favorable settlement agreement with U. S. government with positive earnings impact of approx. EUR 175 million - 2023 earnings outlook raised
-
-
-
-
-
-
-
Fresenius Medical Care (FMS) Reports Q4 EPS of EUR1.36
-
-
-
-
-
-
-
Fresenius Medical Care (FMS) Tops Q3 EPS Views
-
-
-
-
-
-
-
NxStage Reports First Quarter Financial Results
-
1,197,417 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

